Pembrolizumab-Induced Eruptive Keratoacanthomas Managed With Intralesional Corticosteroids: A Case Report
Cureus · 03.05.2026
DOI: 10.7759/cureus.108171 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 03.05.2026. Verfasst von Kevin Varghese und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, University of Kansas Medical Center, Kansas City, USA. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology, University of Kansas Medical Center, Kansas City, USA.
Zitieren
APA
Varghese, K., Vetos, D., Woods, J., Tate, J., & Wang-Weinman, T. (2026). Pembrolizumab-Induced Eruptive Keratoacanthomas Managed With Intralesional Corticosteroids: A Case Report. Cureus. https://doi.org/10.7759/cureus.108171
Vancouver
Varghese K, Vetos D, Woods J, Tate J, Wang-Weinman T. Pembrolizumab-Induced Eruptive Keratoacanthomas Managed With Intralesional Corticosteroids: A Case Report. Cureus. 2026. doi:10.7759/cureus.108171
BibTeX
@article{Varghese2026,
author = {Varghese, Kevin and Vetos, Develyn and Woods, Jason and Tate, Jesalyn and Wang-Weinman, Ting},
title = {Pembrolizumab-Induced Eruptive Keratoacanthomas Managed With Intralesional Corticosteroids: A Case Report},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.108171}
}
EUVIMED